|
|
1.
|
The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma. MedStar authors:
- Abdussamad, Maryam
- Zapas, John
- Zhou, Hengbo
Year: 2017
Citation: - Oncotarget. 8(8):12576-12595, 2017 Feb 21
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Abdussamad M, Atkins MB, Byers SW, Calvert V, Chen YS, Dakshanamurthy S, Fang HB, Gaur A, Petricoin EF, Rosenthal DS, Simbulan-Rosenthal CM, Zapas J, Zhou H
|
|
|
2.
|
Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. MedStar authors:
Year: 2022
Citation: - International Journal of Molecular Sciences. 23(4), 2022 Feb 20.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Alobaidi R, Carney B, Clark H, Dougherty R, Haribabu Y, Kuo LW, Rosenthal DS, Simbulan-Rosenthal CM, Sykora P, Vakili S
|
